Table 1.
Variables and measures used in each phase of the study
| Variables | Measures | Baseline | T1 | T2 | T3 |
|---|---|---|---|---|---|
| Independent/predictor | |||||
| COVID-19 epidemiology and public health measures | OxCGRT | X | X | X | X |
| Demographic variables | 14 questions | X | |||
| Perinatal health care experiences related with COVID-19 | COPE-IS | X | |||
| COVID-19 exposures and symptoms | COPE-IS; COPE-IU | X | X | X | X |
| COVID-19 financial impact | COPE-IS; COPE-CF | X | X | X | X |
| COVID-19 social support impact | COPE IS; COPE-CF | X | X | X | X |
| COVID-19 coping strategies | COPE-IS; COPE-IU | X | X | X | X |
| COVID-19 emotional impact | COPE-IS; COPE-IU | X | X | X | X |
| Health background, mental health, and substance use | COPE-IS | X | |||
| Psychological distress | BSI-18 | X | X | X | X |
| Dependent/outcome | |||||
| Depression symptoms | EPDS | X | X | X | X |
| Anxiety symptoms | GAD-7 | X | X | X | X |
| PTSD symptoms | 10 questions from PTSD Checklist for DSM-5 included in COPE-IS; COPE-IU | X | X | X | X |
T1: 1-month follow-up; T2: 3-month follow-up; T3: 6-month follow-up; PTSD: Post-traumatic Stress Disorder; OxCGRT: Oxford COVID-19 Government Response Tracker; COPE-IS: Coronavirus Perinatal Experiences - Impact Survey; COPE-IU: Coronavirus Perinatal Experiences Scale - Impact Update; COPE-CF: Coronavirus Perinatal Experiences Scale - Care Follow Up; BSI-18: Brief Symptom Inventory-18; EPDS: Edinburgh Postnatal Depression Scale; GAD-7: Generalized Anxiety Disorder Screener